In vitro susceptibility of clinically important zygomycetes to combinations of amphotericin B and suramin

L. Galgóczy, L. Ördögh, M. Virágh, T. Papp, C. Vágvölgyi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The in vitro antifungal activity of suramin (25-300 μg/ml) and its combinations with amphotericin B (0.024-12.5 μg/ml) against 15 zygomycetes isolates representing nine clinically important genera (Absidia, Micromucor, Mortierella, Mycocladus, Mucor, Rhizomucor, Rhizopus, Saksenaea and Syncephalastrum) were tested. The investigated compounds acted antagonistically, synergistically and/or additively on the growth when a strain was sensitive to both compounds or resistant to suramin and sensitive to amphotericin B. At the same time, synergistic interactions were detected if strains were insensitive to both agents. In the case, when a fungus was sensitive to suramin but resistant to amphotericin B, inhibitory effect of only the suramin was measured.

Original languageEnglish
Pages (from-to)241-247
Number of pages7
JournalJournal de Mycologie Medicale
Volume19
Issue number4
DOIs
Publication statusPublished - Dec 2009

Fingerprint

Suramin
Amphotericin B
Absidia
Mortierella
Rhizomucor
Mucor
Rhizopus
Fungi
In Vitro Techniques
Growth

Keywords

  • Amphotericin B
  • Drug combinations
  • MIC
  • Suramin
  • Zygomycetes

ASJC Scopus subject areas

  • Infectious Diseases

Cite this

In vitro susceptibility of clinically important zygomycetes to combinations of amphotericin B and suramin. / Galgóczy, L.; Ördögh, L.; Virágh, M.; Papp, T.; Vágvölgyi, C.

In: Journal de Mycologie Medicale, Vol. 19, No. 4, 12.2009, p. 241-247.

Research output: Contribution to journalArticle

@article{8519bca817ca4ba5887fc861bac56660,
title = "In vitro susceptibility of clinically important zygomycetes to combinations of amphotericin B and suramin",
abstract = "The in vitro antifungal activity of suramin (25-300 μg/ml) and its combinations with amphotericin B (0.024-12.5 μg/ml) against 15 zygomycetes isolates representing nine clinically important genera (Absidia, Micromucor, Mortierella, Mycocladus, Mucor, Rhizomucor, Rhizopus, Saksenaea and Syncephalastrum) were tested. The investigated compounds acted antagonistically, synergistically and/or additively on the growth when a strain was sensitive to both compounds or resistant to suramin and sensitive to amphotericin B. At the same time, synergistic interactions were detected if strains were insensitive to both agents. In the case, when a fungus was sensitive to suramin but resistant to amphotericin B, inhibitory effect of only the suramin was measured.",
keywords = "Amphotericin B, Drug combinations, MIC, Suramin, Zygomycetes",
author = "L. Galg{\'o}czy and L. {\"O}rd{\"o}gh and M. Vir{\'a}gh and T. Papp and C. V{\'a}gv{\"o}lgyi",
year = "2009",
month = "12",
doi = "10.1016/j.mycmed.2009.09.004",
language = "English",
volume = "19",
pages = "241--247",
journal = "Journal de Mycologie Medicale",
issn = "1156-5233",
publisher = "Elsevier Masson",
number = "4",

}

TY - JOUR

T1 - In vitro susceptibility of clinically important zygomycetes to combinations of amphotericin B and suramin

AU - Galgóczy, L.

AU - Ördögh, L.

AU - Virágh, M.

AU - Papp, T.

AU - Vágvölgyi, C.

PY - 2009/12

Y1 - 2009/12

N2 - The in vitro antifungal activity of suramin (25-300 μg/ml) and its combinations with amphotericin B (0.024-12.5 μg/ml) against 15 zygomycetes isolates representing nine clinically important genera (Absidia, Micromucor, Mortierella, Mycocladus, Mucor, Rhizomucor, Rhizopus, Saksenaea and Syncephalastrum) were tested. The investigated compounds acted antagonistically, synergistically and/or additively on the growth when a strain was sensitive to both compounds or resistant to suramin and sensitive to amphotericin B. At the same time, synergistic interactions were detected if strains were insensitive to both agents. In the case, when a fungus was sensitive to suramin but resistant to amphotericin B, inhibitory effect of only the suramin was measured.

AB - The in vitro antifungal activity of suramin (25-300 μg/ml) and its combinations with amphotericin B (0.024-12.5 μg/ml) against 15 zygomycetes isolates representing nine clinically important genera (Absidia, Micromucor, Mortierella, Mycocladus, Mucor, Rhizomucor, Rhizopus, Saksenaea and Syncephalastrum) were tested. The investigated compounds acted antagonistically, synergistically and/or additively on the growth when a strain was sensitive to both compounds or resistant to suramin and sensitive to amphotericin B. At the same time, synergistic interactions were detected if strains were insensitive to both agents. In the case, when a fungus was sensitive to suramin but resistant to amphotericin B, inhibitory effect of only the suramin was measured.

KW - Amphotericin B

KW - Drug combinations

KW - MIC

KW - Suramin

KW - Zygomycetes

UR - http://www.scopus.com/inward/record.url?scp=70849137348&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70849137348&partnerID=8YFLogxK

U2 - 10.1016/j.mycmed.2009.09.004

DO - 10.1016/j.mycmed.2009.09.004

M3 - Article

AN - SCOPUS:70849137348

VL - 19

SP - 241

EP - 247

JO - Journal de Mycologie Medicale

JF - Journal de Mycologie Medicale

SN - 1156-5233

IS - 4

ER -